BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
VCs Invest $23M In Roche Holding Spinout Afferent Pharmaceuticals
News | 12. 16. 2009
Afferent Pharmaceuticals
Venture firms are investing $23 million to spin out a start-up from Roche Holding Ltd. that plans to attack chronic pain in a new way.
